Melanoma – Friday Pop Quiz 6/26
This 32-year-old man has two sisters each with melanoma, and his father died from metastatic pancreatic cancer. You suspect a germline mutation in which of the following genes?
A. BAP1
B. TERT
C. MITF
D. CDKN2A
E. PTCH
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
…
This 32-year-old man has two sisters each with melanoma, and his father died from metastatic pancreatic cancer. You suspect a germline mutation in which of the following genes?
A. BAP1
B. TERT
C. MITF
D. CDKN2A
E. PTCH
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
What is the classic radiologic findings associated with this disorder?
A. Dural calcifications
B. Calcifications of the falx-cerebri
C. Tram-track calcifications of the temporal and occipital cortex
D. Osteopatha striata
E. Osteopoikilosis
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of San … 
A 35 year old female is found to have mismatch repair protein mutations and this finding. Which of the following is the next best step?
A. Check BUN/Cr
B. Check TSH/T4
C. Positron emission tomography
D. Urinary cytology
E. CT Head
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks. … 
Here are the June JDD Issue Highlights:
Guest Editor Dr. James Q. Del Rosso stresses that even the best case scenario of teledermatology can never offer the same as a live in-person visit in Virtual Exams No Substitute for In-Person Care of Acne and Rosacea.
Treating Inflammation in Rosacea: Current Options and Unmet Needs, authors discuss the underlying inflammatory nature of rosacea, tre … 
The patient developed this cutaneous adverse event 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A. Epidermal growth factor receptor (EGFR) inhibitor
B. Tumor necrosis factor (TNF)-alpha inhibitor
C. Smoothened inhibitor
D. BRAF inhibitor
E. Programmed cell death (PD)-1 inhibitor
To find out the correct answer and … 